Cargando…

Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals

Understanding humoral immune responses to SARS-CoV-2 infection will play a critical role in the development of vaccines and antibody-based interventions. We report systemic and mucosal antibody responses in convalescent individuals who experienced varying severity of disease. Whereas assessment of n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Butler, Savannah E., Crowley, Andrew R., Natarajan, Harini, Xu, Shiwei, Weiner, Joshua A., Bobak, Carly A., Mattox, Daniel E., Lee, Jiwon, Wieland-Alter, Wendy, Connor, Ruth I., Wright, Peter F., Ackerman, Margaret E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876222/ https://www.ncbi.nlm.nih.gov/pubmed/33584712 http://dx.doi.org/10.3389/fimmu.2020.618685

Ejemplares similares

Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma
por: Natarajan, Harini, et al.
Publicado: (2021)

SARS-CoV-2 antibody signatures robustly predict diverse antiviral functions relevant for convalescent plasma therapy
por: Natarajan, Harini, et al.
Publicado: (2020)

Longitudinal Systemic and Mucosal Immune Responses to SARS-CoV-2 Infection( )
por: Wright, Peter F, et al.
Publicado: (2022)

Mucosal immunity to poliovirus
por: Connor, Ruth I., et al.
Publicado: (2021)

Boosting of Cross-Reactive Antibodies to Endemic Coronaviruses by SARS-CoV-2 Infection but not Vaccination with Stabilized Spike
por: Crowley, Andrew R., et al.
Publicado: (2021)

Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike
por: Crowley, Andrew R, et al.
Publicado: (2022)

Antibody Attributes that Predict the Neutralization and Effector Function of Polyclonal Responses to SARS-CoV-2
por: Natarajan, Harini, et al.
Publicado: (2021)

Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2
por: Natarajan, Harini, et al.
Publicado: (2022)

Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality
por: Morgenlander, William, et al.
Publicado: (2020)

Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infants
por: Wright, Peter F, et al.
Publicado: (2016)

Optimization and qualification of an Fc Array assay for assessments of antibodies against HIV-1/SIV
por: Brown, Eric P., et al.
Publicado: (2018)

Intestinal Antibody Responses to 2 Novel Live Attenuated Type 2 Oral Poliovirus Vaccines in Healthy Adults in Belgium
por: Brickley, Elizabeth B, et al.
Publicado: (2020)

HUMORAL ANTIBODIES AND RESISTANCE OF VACCINATED AND CONVALESCENT MONKEYS TO POLIOMYELITIS VIRUS
por: Sabin, Albert B., et al.
Publicado: (1936)

Humoral and cellular response in convalescent COVID-19 lupus patients
por: Solé, Cristina, et al.
Publicado: (2022)

The Antibodiome—Mapping the Humoral Immune Response to HIV
por: Butler, Audrey L., et al.
Publicado: (2019)

Impaired humoral immunity to BQ.1.1 in convalescent and vaccinated patients
por: Dewald, Felix, et al.
Publicado: (2023)

Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals
por: Beaudoin-Bussières, Guillaume, et al.
Publicado: (2020)

Tracking the Trajectory of Functional Humoral Immune Responses Following Acute HIV Infection
por: Jennewein, Madeleine F., et al.
Publicado: (2020)

Sex differences in vaccine-induced humoral immunity
por: Fischinger, Stephanie, et al.
Publicado: (2018)

Convalescent plasma-mediated resolution of COVID-19 in a patient with humoral immunodeficiency
por: Honjo, Kazuhito, et al.
Publicado: (2020)

Mining for humoral correlates of HIV control and latent reservoir size
por: Das, Jishnu, et al.
Publicado: (2020)

Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine
por: Brickley, Elizabeth B, et al.
Publicado: (2018)

Intestinal Immunity to Poliovirus Following Sequential Trivalent Inactivated Polio Vaccine/Bivalent Oral Polio Vaccine and Trivalent Inactivated Polio Vaccine–only Immunization Schedules: Analysis of an Open-label, Randomized, Controlled Trial in Chilean Infants
por: Brickley, Elizabeth B, et al.
Publicado: (2018)

High‐resolution definition of humoral immune response correlates of effective immunity against HIV
por: Alter, Galit, et al.
Publicado: (2018)

Llanfairfechan Convalescent Home
por: Butler, Anna M.
Publicado: (1887)

Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab
por: Adamec, Ivan, et al.
Publicado: (2022)

Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement
por: Lofano, Giuseppe, et al.
Publicado: (2018)

Intestinal antibody responses to a live oral poliovirus vaccine challenge among adults previously immunized with inactivated polio vaccine in Sweden
por: Brickley, Elizabeth B, et al.
Publicado: (2019)

A Randomized Phase 4 Study of Immunogenicity and Safety After Monovalent Oral Type 2 Sabin Poliovirus Vaccine Challenge in Children Vaccinated with Inactivated Poliovirus Vaccine in Lithuania
por: Bandyopadhyay, Ananda S, et al.
Publicado: (2020)

Humoral Response in SARS-CoV-2 Convalescent Compared to Vaccinated Kidney Transplant Patients
por: Schimpf, Judith, et al.
Publicado: (2022)

Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
por: Ni, Ling, et al.
Publicado: (2020)

Changes in the humoral immunity response in SARS-CoV-2 convalescent patients over 8 months
por: Peng, Pai, et al.
Publicado: (2021)

Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis
por: Zabalza, Ana, et al.
Publicado: (2022)

Treatment of COVID-19 with convalescent plasma in patients with humoral immunodeficiency – Three consecutive cases and review of the literature
por: Delgado-Fernández, Marcial, et al.
Publicado: (2022)

SARS-CoV-2 humoral and cellular immune responses in COVID-19 convalescent individuals with HIV()
por: Giannone, Denise, et al.
Publicado: (2022)

Treatment of COVID-19 with convalescent plasma in patients with humoral immunodeficiency – Three consecutive cases and review of the literature
por: Delgado-Fernández, Marcial, et al.
Publicado: (2022)

Scarlet Fever Convalescents
por: Gladstone, W. E.
Publicado: (1887)

HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies
por: Richardson, Simone I., et al.
Publicado: (2018)

P1541: CONVALESCENCE NEW LIQUID COOLING THERAPY ON PREVENTION AND TREATMENT OF CHEMOTHERAPEUTIC ORAL MUCOSITIS
por: He, Yang, et al.
Publicado: (2023)

Brief Considerations Relating to Convalescence
por: Rowell, E. E.
Publicado: (1905)

Cannot write session to /tmp/vufind_sessions/sess_isjtiqdsci1cfd3e40el8dqrl8